These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2186951)

  • 1. A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups.
    Euler AR; Safdi M; Rao J; Jaszewski R; Welsh J; Le V; Raskin J; Fleischmann R; Razzaque M; Champion C
    Gastroenterology; 1990 Jun; 98(6):1549-57. PubMed ID: 2186951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multiclinic trial evaluating arbaprostil [15(R)-15-methyl prostaglandin E2] as a therapeutic agent for gastric ulcer.
    Euler AR; Popiela T; Tytgat GN; Kulig J; Lookabaugh JL; Phan TD; Kitt MM
    Gastroenterology; 1989 Apr; 96(4):967-71. PubMed ID: 2647578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 15(R)-15-methyl prostaglandin E2 (Arbacet) on the healing of aspirin or nonsteroidal antiinflammatory drug-induced gastric mucosal lesions: an endoscopic study.
    Jaszewski R; Crane SA
    Am J Gastroenterol; 1987 Dec; 82(12):1271-4. PubMed ID: 3318402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arbaprostil [15(R)-15-methyl prostaglandin E2] in a single nighttime dose of either 50 or 100 micrograms in acute duodenal ulcer.
    Euler AR; Bailey RJ; Zinny MA; Brandon ML; Rousseau B; Ferguson JP; Wood DR; Le VH
    Gastroenterology; 1989 Jul; 97(1):98-103. PubMed ID: 2656368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of arbaprostil at multiple doses for the treatment of acute duodenal ulcer: a randomized double-blind placebo-controlled international trial.
    Euler AR; Krawiec J; Odes H; Gilat T; Garcia L; Rachmilewitz D; Gabryelewicz A; Gibinski K; Bass D; Barbara L
    Am J Gastroenterol; 1990 Feb; 85(2):145-9. PubMed ID: 2405642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
    Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
    Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of a cytoprotective dose of Arbacet to heal acute gastric ulcers.
    Jaszewski R; Crane SA
    Am J Gastroenterol; 1988 Jul; 83(7):734-6. PubMed ID: 3289379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of a cytoprotective dose of arbaprostil to heal acute duodenal ulcers. Results of a multiclinic trial.
    Euler AR; Tytgat G; Berenguer J; Brunner H; Wood DR; Lookabaugh JL; Phan TD
    Gastroenterology; 1987 Mar; 92(3):604-7. PubMed ID: 3545965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study.
    Gilbert DA; Surawicz CM; Silverstein FE; Weinberg CR; Saunders DR; Feld AD; Sanford RL; Bergman D; Washington P
    Gastroenterology; 1984 Feb; 86(2):339-45. PubMed ID: 6360786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on gastric secretion and various gastric lesions induced in rats.
    Okabe S; Jino H; Nishida A
    Jpn J Pharmacol; 1986 Feb; 40(2):329-37. PubMed ID: 3702150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of treatment with 15/R/15-methyl derivative of prostaglandin E2 on aspirin- and indomethacin-induced damage of the mucous membrane of the upper digestive tract in rheumatoid arthritis patients].
    Mach T; Bogdał J; Stachura J; Kirchmayer S
    Pol Tyg Lek; 1987 Sep; 42(38):1183-5. PubMed ID: 3438193
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study.
    Vantrappen G; Janssens J; Popiela T; Kulig J; Tytgat GN; Huibregtse K; Lambert R; Pauchard JP; Robert A
    Gastroenterology; 1982 Aug; 83(2):357-63. PubMed ID: 7044880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misoprostol in the prevention of NSAID-induced gastric ulcer: a multicenter, double-blind, placebo-controlled trial.
    Roth SH
    J Rheumatol Suppl; 1990 Feb; 20():20-4. PubMed ID: 2109073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the synthesized prostaglandin E2-analogue arbaprostil on gastric mucosal lesions in rats.
    Sugiyama S; Kawabe Y; Kuroiwa M; Goto H; Tsukamoto Y; Ozawa T
    Arzneimittelforschung; 1989 Dec; 39(12):1571-3. PubMed ID: 2624606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients.
    Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Ardizzone S
    Scand J Gastroenterol; 1993 Oct; 28(10):875-8. PubMed ID: 8266016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSAID-induced gastric injury: its pathogenesis and management.
    Earnest DL
    Semin Arthritis Rheum; 1990 Feb; 19(4 Suppl 2):6-10. PubMed ID: 2181675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoprotective doses of arbacet with minimal antisecretory properties are not effective in duodenal ulcer healing.
    Wengrower D; Fich A; Goldin E; Eliakim R; Ligumsky M; Rachmilewitz D
    Dig Dis Sci; 1987 Aug; 32(8):857-60. PubMed ID: 3608733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
    Agrawal NM; Dajani EZ
    J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.